Effect of Aerobic Training in Moderate or Severe Asthmatic Patients (ETA1)
Effect of Aerobic Training on Bronchial Hyperresponsiveness and Systemic Inflammation in Patients With Moderate or Severe Asthma: a Randomized Controlled Trial
Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo
A PHASE3 clinical study on Asthma., this trial is ongoing. The trial is conducted by Fundação de Amparo à Pesquisa do Estado de São Paulo and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Instituto de Investigação em Imunologia
- University of Sao Paulo
For direct contact, visit the study record on ClinicalTrials.gov .